Invention Grant
- Patent Title: Bicyclic pyrimidine compounds
- Patent Title (中): 双环嘧啶化合物
-
Application No.: US14148775Application Date: 2014-01-07
-
Publication No.: US08969555B2Publication Date: 2015-03-03
- Inventor: Thomas James Beauchamp , Yen Dao , Spencer Brian Jones , Bryan Hurst Norman , Lance Allen Pfeifer
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Macharri R. Vorndran-Jones
- Main IPC: C07D239/70
- IPC: C07D239/70 ; C07D487/04 ; C07D471/04

Abstract:
The present invention provides compounds of the Formula I: wherein X is a bond or CH2; R is selected from the group consisting of R1 and R2 are each independently selected from the group consisting of CH and N; R3 is H or CH3; R4 is H or CH3; L is selected from the group consisting of —O(CH2)3—, —C(O)NH(CH2)2—, —CH2C(O)NH(CH2)2—, —(CH2)3N(C(O)CH3)CH2—, —(CH2)2N(C(O)CH3)CH2—, —(CH2)3NH—, (CH2)2OCH2—, —(CH2)4—, —(CH2)2NHCH2—, —(CH2)3O—, and —CH2O(CH2)2—; or a pharmaceutically acceptable salt thereof. Compounds of this invention are autotaxin inhibitors.
Public/Granted literature
- US20140200231A1 Bicyclic Pyrimidine Compounds Public/Granted day:2014-07-17
Information query